Merck shells out $10 billion for London-based lung therapy firm Verona
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
